ID   NOS3_RAT                Reviewed;        1202 AA.
AC   Q62600; O88672; O89041; Q62734; Q68GV6; Q75NE4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   24-JUL-2024, entry version 198.
DE   RecName: Full=Nitric oxide synthase 3 {ECO:0000312|RGD:3186};
DE            EC=1.14.13.39 {ECO:0000250|UniProtKB:P29474};
DE   AltName: Full=Constitutive NOS;
DE            Short=cNOS;
DE   AltName: Full=EC-NOS;
DE   AltName: Full=NOS type III;
DE            Short=NOSIII;
DE   AltName: Full=Nitric oxide synthase, endothelial {ECO:0000305};
DE            Short=Endothelial NOS {ECO:0000305};
DE            Short=eNOS {ECO:0000305};
GN   Name=Nos3 {ECO:0000312|RGD:3186};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=15105416; DOI=10.1074/jbc.m401471200;
RA   Saitoh F., Tian Q.B., Okano A., Sakagami H., Kondo H., Suzuki T.;
RT   "NIDD, a novel DHHC-containing protein, targets neuronal nitric-oxide
RT   synthase (nNOS) to the synaptic membrane through a PDZ-dependent
RT   interaction and regulates nNOS activity.";
RL   J. Biol. Chem. 279:29461-29468(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-288.
RC   STRAIN=Sprague-Dawley;
RA   Toporsian M., Govindaraju K., Nagi M., Eidelman D., Thibault G., Ward M.E.;
RT   "Downregulation of endothelial nitric oxide synthase (NOS III) in rat aorta
RT   following in-vivo hypoxia.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-1202.
RC   STRAIN=SS/JrHsdMcwi; TISSUE=Heart;
RX   PubMed=15808839; DOI=10.1016/j.yjmcc.2005.02.005;
RA   Shi Y., Hutchins W., Ogawa H., Chang C.-C., Pritchard K.A. Jr., Zhang C.,
RA   Khampang P., Lazar J., Jacob H.J., Rafiee P., Baker J.E.;
RT   "Increased resistance to myocardial ischemia in the Brown Norway vs. Dahl S
RT   rat: role of nitric oxide synthase and Hsp90.";
RL   J. Mol. Cell. Cardiol. 38:625-635(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 473-672 AND 951-1192.
RC   TISSUE=Brain;
RA   Seidel B., Jiang L., Wolf G.;
RT   "Cloning and expression of the rat endothelial nitric oxide synthase.";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 633-862.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=7527874; DOI=10.1038/ki.1994.318;
RA   Mohaupt M.G., Elzie J.L., Ahn K.Y., Clapp W.L., Wilcox C.S., Kone B.C.;
RT   "Differential expression and induction of mRNAs encoding two inducible
RT   nitric oxide synthases in rat kidney.";
RL   Kidney Int. 46:653-665(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1015-1132.
RC   STRAIN=Sprague-Dawley; TISSUE=Lung;
RA   Minchenko A.G., Armstead V.E., Opentanova I.L., Lefer A.M.;
RT   "Endothelin-1, endothelin receptors and ecNOS mRNA expression in vital
RT   organs during traumatic shock in rats.";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1018-1080.
RC   STRAIN=Sprague-Dawley; TISSUE=Lung;
RX   PubMed=7537461; DOI=10.1152/ajplung.1995.268.4.l589;
RA   Kawai N., Bloch D.B., Filippov G., Rabkina D., Suen H.C., Losty P.D.,
RA   Janssens S.P., Zapol W.M., de la Monte S., Bloch K.D.;
RT   "Constitutive endothelial nitric oxide synthase gene expression is
RT   regulated during lung development.";
RL   Am. J. Physiol. 268:L589-L595(1995).
RN   [8]
RP   PHOSPHORYLATION AT THR-494 AND SER-1176.
RX   PubMed=10025949; DOI=10.1016/s0014-5793(98)01705-0;
RA   Chen Z.P., Mitchelhill K.I., Michell B.J., Stapleton D.,
RA   Rodriguez-Crespo I., Witters L.A., Power D.A., Ortiz de Montellano P.R.,
RA   Kemp B.E.;
RT   "AMP-activated protein kinase phosphorylation of endothelial NO synthase.";
RL   FEBS Lett. 443:285-289(1999).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1174 AND SER-1176, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Produces nitric oxide (NO) which is implicated in vascular
CC       smooth muscle relaxation through a cGMP-mediated signal transduction
CC       pathway. NO mediates vascular endothelial growth factor (VEGF)-induced
CC       angiogenesis in coronary vessels and promotes blood clotting through
CC       the activation of platelets. {ECO:0000250|UniProtKB:P29474}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + 2 L-arginine + 3 NADPH + 4 O2 = 4 H2O + 2 L-citrulline
CC         + 3 NADP(+) + 2 nitric oxide; Xref=Rhea:RHEA:19897,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16480, ChEBI:CHEBI:32682, ChEBI:CHEBI:57743,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.14.13.39;
CC         Evidence={ECO:0000250|UniProtKB:P29474};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19898;
CC         Evidence={ECO:0000250|UniProtKB:P29474};
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344;
CC         Evidence={ECO:0000250|UniProtKB:P29474};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000250|UniProtKB:P29476};
CC       Note=Binds 1 FAD. {ECO:0000250|UniProtKB:P29476};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000250|UniProtKB:P35228};
CC       Note=Binds 1 FMN. {ECO:0000250|UniProtKB:P35228};
CC   -!- COFACTOR:
CC       Name=(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin;
CC         Xref=ChEBI:CHEBI:59560; Evidence={ECO:0000250|UniProtKB:P35228};
CC       Note=Tetrahydrobiopterin (BH4). May stabilize the dimeric form of the
CC       enzyme. {ECO:0000250|UniProtKB:P35228};
CC   -!- ACTIVITY REGULATION: Stimulated by calcium/calmodulin. Inhibited by
CC       NOSIP and NOSTRIN (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Interacts with NOSIP and NOSTRIN (By similarity).
CC       Interacts with HSP90AB1 (By similarity). Forms a complex with ASL, ASS1
CC       and SLC7A1; the complex regulates cell-autonomous L-arginine synthesis
CC       and citrulline recycling while channeling extracellular L-arginine to
CC       nitric oxide synthesis pathway (By similarity).
CC       {ECO:0000250|UniProtKB:P29474, ECO:0000250|UniProtKB:P70313}.
CC   -!- INTERACTION:
CC       Q62600; P62157: CALM; Xeno; NbExp=2; IntAct=EBI-7052018, EBI-397403;
CC   -!- SUBCELLULAR LOCATION: Membrane, caveola {ECO:0000250}. Cytoplasm,
CC       cytoskeleton {ECO:0000250}. Golgi apparatus {ECO:0000250}. Cell
CC       membrane {ECO:0000250}. Note=Specifically associates with actin
CC       cytoskeleton in the G2 phase of the cell cycle, which is favored by
CC       interaction with NOSIP and results in a reduced enzymatic activity.
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed constitutively by vascular endothelium.
CC       Detected in alveolar and serosal epithelial cells as well as in
CC       endothelial cells in one day old rat. In adult lung, detected in rare
CC       endothelial cells.
CC   -!- DEVELOPMENTAL STAGE: Detected at high levels in lung during the late
CC       fetal and postnatal period and at lower levels in adult.
CC   -!- PTM: Phosphorylation by AMPK at Ser-1176 in the presence of Ca(2+)-
CC       calmodulin (CaM) activates activity. In absence of Ca(2+)-calmodulin,
CC       AMPK also phosphorylates Thr-494, resulting in inhibition of activity.
CC       {ECO:0000269|PubMed:10025949}.
CC   -!- SIMILARITY: Belongs to the NOS family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB176831; BAD15356.1; -; mRNA.
DR   EMBL; AF085195; AAC34677.1; -; mRNA.
DR   EMBL; AY695391; AAT99567.1; -; mRNA.
DR   EMBL; AJ011115; CAA09493.1; -; mRNA.
DR   EMBL; AJ011116; CAA09494.1; -; mRNA.
DR   EMBL; U02534; AAA96141.1; -; mRNA.
DR   EMBL; AF093837; AAC64178.1; -; mRNA.
DR   EMBL; U18336; AAC52188.1; -; mRNA.
DR   PIR; I51917; I51917.
DR   PIR; I56979; I56979.
DR   RefSeq; NP_068610.1; NM_021838.2.
DR   AlphaFoldDB; Q62600; -.
DR   BMRB; Q62600; -.
DR   SMR; Q62600; -.
DR   CORUM; Q62600; -.
DR   DIP; DIP-41833N; -.
DR   IntAct; Q62600; 2.
DR   MINT; Q62600; -.
DR   STRING; 10116.ENSRNOP00000013058; -.
DR   BindingDB; Q62600; -.
DR   ChEMBL; CHEMBL1075230; -.
DR   GlyGen; Q62600; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q62600; -.
DR   PhosphoSitePlus; Q62600; -.
DR   SwissPalm; Q62600; -.
DR   PaxDb; 10116-ENSRNOP00000013058; -.
DR   GeneID; 24600; -.
DR   KEGG; rno:24600; -.
DR   AGR; RGD:3186; -.
DR   CTD; 4846; -.
DR   RGD; 3186; Nos3.
DR   eggNOG; KOG1158; Eukaryota.
DR   InParanoid; Q62600; -.
DR   OrthoDB; 276396at2759; -.
DR   PhylomeDB; Q62600; -.
DR   BRENDA; 1.14.13.39; 5301.
DR   Reactome; R-RNO-1222556; ROS and RNS production in phagocytes.
DR   Reactome; R-RNO-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-RNO-203615; eNOS activation.
DR   Reactome; R-RNO-203641; NOSTRIN mediated eNOS trafficking.
DR   Reactome; R-RNO-203754; NOSIP mediated eNOS trafficking.
DR   Reactome; R-RNO-392154; Nitric oxide stimulates guanylate cyclase.
DR   Reactome; R-RNO-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-RNO-9009391; Extra-nuclear estrogen signaling.
DR   SABIO-RK; Q62600; -.
DR   PRO; PR:Q62600; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0045177; C:apical part of cell; IDA:RGD.
DR   GO; GO:0005901; C:caveola; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0042383; C:sarcolemma; IDA:RGD.
DR   GO; GO:0003779; F:actin binding; IDA:RGD.
DR   GO; GO:0003785; F:actin monomer binding; ISO:RGD.
DR   GO; GO:0034618; F:arginine binding; ISO:RGD.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:RGD.
DR   GO; GO:0045296; F:cadherin binding; IPI:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IDA:RGD.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IBA:GO_Central.
DR   GO; GO:0010181; F:FMN binding; IBA:GO_Central.
DR   GO; GO:0020037; F:heme binding; ISO:RGD.
DR   GO; GO:0051879; F:Hsp90 protein binding; IDA:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0004517; F:nitric-oxide synthase activity; IDA:RGD.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; IPI:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:RGD.
DR   GO; GO:0034617; F:tetrahydrobiopterin binding; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0003180; P:aortic valve morphogenesis; ISO:RGD.
DR   GO; GO:0006527; P:arginine catabolic process; ISO:RGD.
DR   GO; GO:0097746; P:blood vessel diameter maintenance; ISO:RGD.
DR   GO; GO:0001974; P:blood vessel remodeling; ISO:RGD.
DR   GO; GO:0060348; P:bone development; IEP:RGD.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; IEP:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0034605; P:cellular response to heat; IEP:RGD.
DR   GO; GO:0071403; P:cellular response to high density lipoprotein particle stimulus; IEP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; IEP:RGD.
DR   GO; GO:0071286; P:cellular response to magnesium ion; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IMP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:1904648; P:cellular response to rotenone; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IMP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0003203; P:endocardial cushion morphogenesis; ISO:RGD.
DR   GO; GO:0043542; P:endothelial cell migration; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0030324; P:lung development; ISO:RGD.
DR   GO; GO:0070168; P:negative regulation of biomineral tissue development; ISO:RGD.
DR   GO; GO:0045776; P:negative regulation of blood pressure; IBA:GO_Central.
DR   GO; GO:0051926; P:negative regulation of calcium ion transport; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0014740; P:negative regulation of muscle hyperplasia; ISO:RGD.
DR   GO; GO:0043267; P:negative regulation of potassium ion transport; ISO:RGD.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0006809; P:nitric oxide biosynthetic process; IMP:RGD.
DR   GO; GO:0007263; P:nitric oxide mediated signal transduction; IBA:GO_Central.
DR   GO; GO:0046209; P:nitric oxide metabolic process; IEP:RGD.
DR   GO; GO:0001542; P:ovulation from ovarian follicle; ISO:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0006813; P:potassium ion transport; ISO:RGD.
DR   GO; GO:0003184; P:pulmonary valve morphogenesis; ISO:RGD.
DR   GO; GO:0031644; P:regulation of nervous system process; ISO:RGD.
DR   GO; GO:0002028; P:regulation of sodium ion transport; ISO:RGD.
DR   GO; GO:0003100; P:regulation of systemic arterial blood pressure by endothelin; ISO:RGD.
DR   GO; GO:0003057; P:regulation of the force of heart contraction by chemical signal; ISO:RGD.
DR   GO; GO:0019430; P:removal of superoxide radicals; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0043200; P:response to amino acid; IEP:RGD.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0009743; P:response to carbohydrate; IEP:RGD.
DR   GO; GO:0051412; P:response to corticosterone; IEP:RGD.
DR   GO; GO:0034097; P:response to cytokine; IEP:RGD.
DR   GO; GO:0036017; P:response to erythropoietin; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IDA:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0034405; P:response to fluid shear stress; ISO:RGD.
DR   GO; GO:0009750; P:response to fructose; IEP:RGD.
DR   GO; GO:0009725; P:response to hormone; IBA:GO_Central.
DR   GO; GO:0055093; P:response to hyperoxia; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:1901654; P:response to ketone; IEP:RGD.
DR   GO; GO:1903576; P:response to L-arginine; IEP:RGD.
DR   GO; GO:0010288; P:response to lead ion; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0071000; P:response to magnetism; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0046689; P:response to mercury ion; IEP:RGD.
DR   GO; GO:0010038; P:response to metal ion; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:1901652; P:response to peptide; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:1902074; P:response to salt; IEP:RGD.
DR   GO; GO:1990478; P:response to ultrasound; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEP:RGD.
DR   GO; GO:0014806; P:smooth muscle hyperplasia; ISO:RGD.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISO:RGD.
DR   CDD; cd00795; NOS_oxygenase_euk; 1.
DR   Gene3D; 3.40.50.360; -; 1.
DR   Gene3D; 3.90.440.10; Nitric Oxide Synthase;Heme Domain;Chain A domain 2; 1.
DR   Gene3D; 3.40.50.80; Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module; 1.
DR   Gene3D; 2.40.30.10; Translation factors; 1.
DR   InterPro; IPR003097; CysJ-like_FAD-binding.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001094; Flavdoxin-like.
DR   InterPro; IPR008254; Flavodoxin/NO_synth.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_alpha.
DR   InterPro; IPR050607; NOS.
DR   InterPro; IPR044943; NOS_dom_1.
DR   InterPro; IPR044940; NOS_dom_2.
DR   InterPro; IPR044944; NOS_dom_3.
DR   InterPro; IPR012144; NOS_euk.
DR   InterPro; IPR004030; NOS_N.
DR   InterPro; IPR036119; NOS_N_sf.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   PANTHER; PTHR43410; NITRIC OXIDE SYNTHASE OXYGENASE; 1.
DR   PANTHER; PTHR43410:SF1; NITRIC OXIDE SYNTHASE OXYGENASE; 1.
DR   Pfam; PF00667; FAD_binding_1; 1.
DR   Pfam; PF00258; Flavodoxin_1; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   Pfam; PF02898; NO_synthase; 1.
DR   PIRSF; PIRSF000333; NOS; 1.
DR   PRINTS; PR00369; FLAVODOXIN.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52343; Ferredoxin reductase-like, C-terminal NADP-linked domain; 1.
DR   SUPFAM; SSF52218; Flavoproteins; 1.
DR   SUPFAM; SSF56512; Nitric oxide (NO) synthase oxygenase domain; 1.
DR   SUPFAM; SSF63380; Riboflavin synthase domain-like; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50902; FLAVODOXIN_LIKE; 1.
DR   PROSITE; PS60001; NOS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calmodulin-binding; Cell membrane; Cytoplasm; Cytoskeleton; FAD;
KW   Flavoprotein; FMN; Golgi apparatus; Heme; Iron; Lipoprotein; Membrane;
KW   Metal-binding; Myristate; NADP; Oxidoreductase; Palmitate; Phosphoprotein;
KW   Reference proteome; Zinc.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P29473"
FT   CHAIN           2..1202
FT                   /note="Nitric oxide synthase 3"
FT                   /id="PRO_0000170946"
FT   DOMAIN          519..702
FT                   /note="Flavodoxin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00088"
FT   DOMAIN          755..1001
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   REGION          1..70
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          97..485
FT                   /note="Interaction with NOSIP"
FT                   /evidence="ECO:0000250"
FT   REGION          489..509
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000255"
FT   REGION          817..843
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        35..64
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         93
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homodimeric partners"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         98
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homodimeric partners"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         101
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         183
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         246
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         355
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         356
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         360
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         445
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         446
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         459
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         474
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         525
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         526
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         527
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         529
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         571
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         572
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         653
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         660
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         686
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         690
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         775
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         797
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         937
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         939
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         940
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         955
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         957
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         961
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         974
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         975
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         976
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1015
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1048
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1077
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1078
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1084
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1086
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1088
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   MOD_RES         494
FT                   /note="Phosphothreonine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:10025949"
FT   MOD_RES         614
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70313"
FT   MOD_RES         632
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P29473"
FT   MOD_RES         637
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   MOD_RES         835
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   MOD_RES         1174
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1176
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:10025949,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         1178
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70313"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000250"
FT   LIPID           15
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           26
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CONFLICT        232..233
FT                   /note="QR -> PS (in Ref. 2; AAC34677)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        249
FT                   /note="R -> S (in Ref. 2; AAC34677)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        298..304
FT                   /note="Missing (in Ref. 3; AAT99567)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        600
FT                   /note="P -> L (in Ref. 4; CAA09493)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        735
FT                   /note="R -> G (in Ref. 3; AAT99567)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        739
FT                   /note="Q -> P (in Ref. 3; AAT99567)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        748
FT                   /note="R -> G (in Ref. 1; BAD15356)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        771
FT                   /note="S -> T (in Ref. 3; AAT99567)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        852..854
FT                   /note="CTL -> GTV (in Ref. 5; AAA96141)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        966
FT                   /note="G -> V (in Ref. 1; BAD15356)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        997..998
FT                   /note="SF -> FL (in Ref. 3; AAT99567)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1202 AA;  133290 MW;  52E905C3134E244D CRC64;
     MGNLKSVGQE PGPPCGLGLG LGLGLCGKQG PASPAPEPSQ APVPPSPTRP APDHSPPLTR
     PPDGPKFPRV KNWEVGSITY DTLSAQAQQD GPCTPRRCLG SLVFPRKLQS RPTQGPSPTE
     QLLGQARDFI NQYYNSIKRS GSQAHEQRLQ EVEAEVVATG TYQLRESELV FGAKQAWRNA
     PRCVGRIQWG KLQVFDARDC RTAQEMFTYI CNHIKYATNR GNLRSAITVF PQRYAGRGDF
     RIWNSQLVRY AGYRQQDGSV RGDPANVEIT ELCIQHGWTP GNGRFDVLPL LLQAPDEPPE
     LFTLPPELVL EVPLEHPTLE WFAALGLRWY ALPAVSNMLL EIGGLEFPAA PFSGWYMSSE
     IGMRDLCDPH RYNILEDVAV CMDLDTRTTS SLWKDKAAVE INVAVLYSYQ LAKVTIVDHH
     AATASFMKHL ENEQKARGGC PADWAWIVPP ISGSLTPVFH QEMVNYFLSP AFRYQPDPWK
     GSAAKGTGIT RKKTFKEVAN AVKISASLMG TVMAKRVKAT ILYGSETGRA QSYAQQLGRL
     FRKAFDPRVL CMDEYDVVSL EHEALVLVVT STFGNGDPPE NGESFAAALM EMSGPYNSSP
     RPEQHKSYKI RFNSVSCSDP LVSSWRRKRK ESSNTDSAGA LGTLRFCVFG LGSRAYPHFC
     AFARAVDTRL EELGGERLLQ LGQGDELCGQ EEAFRGWAQA AFQAACETFC VGEDAKAAAR
     DIFSPKRSWK RQRYRLSTQA ESLQLLPRLT HVHRRKMFQA TILSVENLQS SKSTRATILV
     RLDTGSQEGL QYQPGDHIGV CPPNRPGLVE ALLSRVEDPP PSTEPVAVEQ LEKGSPGGPP
     PGWVRDPRLP PCTLRQALTY FLDITSPPSP RLLRLLSTLA EESSEQQELE ALSQDPRRYE
     EWKWFRCPTL LEVLEQFPSV ALPAPLILTQ LPLLQPRYYS VSSAPSAHPG EIHLTVAVLA
     YRTQDGLGPL HYGVCSTWMS QLKAGDPVPC FIRGAPSFRL PPDPNLPCIL VGPGTGIAPF
     RGFWQDRLHD IEIKGLQPAP MTLVFGCRCS QLDHLYRDEV LDAQQRGVFG QVLTAFSRDP
     GSPKTYVQDL LRTELAAEVH RVLCLEQGHM FVCGDVTMAT SVLQTVQRIL ATEGSMELDE
     AGDVIGVLRD QQRYHEDIFG LTLRTQEVTS RIRTQSFSLQ ERQLRGAVPW SFDPPTQETP
     GS
//
